SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-027798
Filing Date
2021-05-14
Accepted
2021-05-14 07:00:41
Documents
10
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20210514.htm 6-K 19202
2 EX-99.1 tlc-ex991_6.htm EX-99.1 177708
3 GRAPHIC ghwu4uyb5wgj000006.jpg GRAPHIC 4467
4 GRAPHIC ghwu4uyb5wgj000008.jpg GRAPHIC 4467
5 GRAPHIC ghwu4uyb5wgj000001.jpg GRAPHIC 2054
6 GRAPHIC ghwu4uyb5wgj000004.jpg GRAPHIC 4467
7 GRAPHIC ghwu4uyb5wgj000003.jpg GRAPHIC 2054
8 GRAPHIC ghwu4uyb5wgj000005.jpg GRAPHIC 2054
9 GRAPHIC ghwu4uyb5wgj000002.jpg GRAPHIC 4467
10 GRAPHIC ghwu4uyb5wgj000007.jpg GRAPHIC 2054
  Complete submission text file 0001564590-21-027798.txt   235121
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 21921901
SIC: 2834 Pharmaceutical Preparations